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A search of the literature and the experiments carried out by the authors of this review show that there are
a number of animal models where the effect of homeopathic dilutions or the principles of homeopathic
medicine have been tested. The results relate to the immunostimulation by ultralow doses of antigens,
the immunological models of the ‘simile’, the regulation of acute or chronic inflammatory processes
and the use of homeopathic medicines in farming. The models utilized by different research groups
are extremely etherogeneous and differ as the test medicines, the dilutions and the outcomes are
concerned. Some experimental lines, particularly those utilizing mice models of immunomodulation
and anti-inflammatory effects of homeopathic complex formulations, give support to a real effect of
homeopathic high dilutions in animals, but often these data are of preliminary nature and have not
been independently replicated. The evidence emerging from animal models is supporting the traditional
‘simile’ rule, according to which ultralow doses of compounds, that in high doses are pathogenic, may
have paradoxically a protective or curative effect. Despite a few encouraging observational studies,
the effectiveness of the homeopathic prevention or therapy of infections in veterinary medicine is not
sufficiently supported by randomized and controlled trials.
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Introduction
Although in recent years we have witnessed a renaissance of
interest in homeopathy, the reliability of its main principles,
the ‘simile’ and the ‘dilution/dynamization’ of medicines,
has still to be demonstrated on the experimental ground and
few studies have been conducted to understand the underlying
mechanism(s). On the other hand, inspection of the literature
and experiments carried out by the authors of this review
show that the principle of similarity—brought back to its
biological meaning, i.e. the inversion of effect of the same or
similar compounds—can be found to be operative in various
experimental and reproducible phenomena (1–4). Therefore,
on the basis of the present knowledge of living systems
and of modern techniques of investigations, a scientific
reformulation of homeopathy and its action mechanisms can
be proposed in order to construct reasonable models, which
could be tested at the different levels of biological systems,
from cells to animals and to human beings. Our general
working hypothesis is that the modern immunological and
pathophysiological knowledge should help to clarify at least
some mechanisms of action of this traditional medicine.
Over the past few years, there has been an increase in
the number of preclinical (in vitro and in vivo) studies aimed
at evaluating the pharmacological activity or efficacy of
some homeopathic remedies under potentially reproducible
conditions; however, in addition to major differences of
experimental models, these studies have also highlighted
a series of methodological difficulties and lack of independent
replication (5).
Many studies of the efficacy and possible mechanisms of
action of homeopathic medicines have been based on tests
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involving experimental animals or isolated organs. They have
included various models of the application of ‘similia’, and
attempted to demonstrate the effects of low doses or high
dilutions of biologically active compounds. The fields of
immunomodulation and inflammation are particularly fertile
from this point of view. Immunoallergology represents a bridge
between homeopathy andmodernmedicine insofar as it is a field
in which it is easier to apply concepts such as the effect of sub-
stances administered on the basis of the logic of the ‘similar’
and the great sensitivity of living systems to regulations.
As it will become clear from the literature review, there
are three different approaches to the exploitation of the
homeopathic ‘simile’:
(i) The concept of ‘similia’, according to which there
is a similitude between the symptoms evoked by
the medicine and the symptoms of natural disease; in
animal research, this modality has been pursued
utilizing both the single medicines and the complex
formulations, even if the latter does not follow the
classical Hahnemann’s rules.
(ii) ‘Isopathy’, according to which the same substance that
causes the disease can be used in low doses or high dilu-
tions to treat the disease; this concept is analog to the
hormesis effect that was discussed in a previous article
(6); when the preparation is from pathological tissues or
microbial products the term ‘nosode therapy’ is also used.
(iii) ‘Iso-endopathy’, where therapeutic effects are obtained
from highly diluted endogenous molecules (hormones,
inflammatory mediators).
In the clinical practice, as in the scientific literature, it is
possible to observe that the specificity and magnitude of
effects are quite different between these forms of therapy.
Therefore, the different concepts should be considered in the
evaluation of the evidence coming from experimental studies
and in the planning of appropriate experimental design.
Below, we describe a series of experimental studies aimed at
verifying the efficacy of homeopathic medicines as immuno-
stimulants and immunoregulators, then we shall examine the
effects of homeopathic dilutions—or of other substances
utilized according to the ‘simile’ principle—on models of
experimental inflammation. Finally, an overview of main
advancements in veterinary homeopathy, i.e. on the fields
where homeopathy is used with the aim to cure natural infec-
tious diseases and diseases of immune system, is provided.
All the literature available in Medline, conference procee-
dings and books was searched, we also report experiments
done in our laboratory. As in the previous article reporting
studies on cellular models, due to the relative scarcity of
literature in this field, the lack of replication articles and
the heterogeneity of experiments, we could not perform
meta-analysis of data.
Homeopathic Immunostimulation
Bastide’s group (7) has shown the immunostimulatory effects
in mice of endogenous compounds such as thymic hormones
and interferons prepared in high dilutions according to homeo-
pathic procedures. Of the many reported experiments, those
describing the effects of high dilutions of a–b interferon
(8–16 · 1010 IU i.p.) and thymic hormones (8 · 108 pg
i.p.) on parameters of humoral (the number of plaque-forming
cells) and cellular immunity (allospecific cytotoxic T cell
responses) are particularly interesting (8). The authors
suggested that a good therapeutic effect could be obtained in
immunodepressed patients by using extremely low doses of
these immunity mediators. Another interesting result coming
from the studies of this group illustrates one of the most
significant problems of homeopathic research: the pathophy-
siological state of the experimental animal powerfully condi-
tions the results of any given treatment. This prompted the
investigators to assess the effect of homeopathic dilutions
(from 4c to 12c)1 of thymus and thymuline on mice of the
Swiss strain (which are considered to be immunologically
normal) and mice of the New Zealand Black strain, which
are considered to be immunologically depressed. The treat-
ment caused significant immunostimulation only in the New
Zealand Black mice, whereas the Swiss mice underwent
immunodepression (which was particularly marked in the
case of the thymus dilutions) (9). Another interesting point
has to do with the importance of the chronological factor:
a given treatment is perceived differently by the organism
depending upon the time of day (circadian rhythm) or the
month of the year (circa-annual rhythm) (8,10).
Ultradiluted Antigens Still Prime Immune System
Other immunomodulatory findings worthy of note are those
reported by Bentwich’s group (11–13). After demonstrating
that very small amounts (6c and 7c dilutions) of the protein
KLH (hemocyanin) antigen are capable of specifically modu-
lating antibody responses in experimental animals, they
repeated and expanded their experiments by showing the
immunostimulating effects of homeopathic dilutions of the
same antigen in mice. The animals were preconditioned for
8 weeks with i.p. injections of dynamized dilutions of KLH
antigen (from 1014 M to 1036 M) or saline (control),
and were then regularly immunized with KLH dissolved in
complete or incomplete Freund’s adjuvant. The serum
levels of specific antibodies were determined by means of
immunoassay and the results showed a significant increase in
specific IgM response at all of the preconditioning dilutions,
as well as a significant increase in specific IgG response in the
animals pretreated with KLH 1036 M. The authors concluded
that extremely small amounts of antigen are enough for spe-
cific immunomodulation and, in particular, that homeopathic
1‘Homeopathic dilutions’, otherwise called ‘homeopathic potencies’, means
solutions of substances diluted and succussed (‘dynamized’ or ‘potentized’
according to traditional terminology) in 1 : 100 serial dilutions (centesimal,
c) or 1 : 10 serial dilutions (decimal, x). According to the Avogadro’s law and
as an approximate reference value, assuming a 1 mol l1 (1M) concentration
of pharmacologically active principles in the starting solution (mother
tincture), dilutions higher than 12c or 24x (concentration of 1024 M) should
contain >1 molecule per liter of active principle.
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dilutions beyond Avogadro’s constant still have some effect.
However, they also acknowledged that, in view of the vast
implications of these findings, the experiments must be
rigorously repeated and confirmed.
Neuroendocrine Regulations at High Dilution
The development of the chicken immune system is stimulated
by homeopathic dilutions of bursin (7,14,15), a tripeptide
(Lys-His-Gly-NH2) B cell differentiation hormone derived
from the bursa fabricii. In these studies, chick embryos under-
went bursectomy in order to make them immunodeficient (it is
well known that the bursa of Fabricius is essential for the
development of the B lymphocyte system). The in ovo admin-
istration of low doses and high dilutions of the hormone bursin
(up to 1040 g ml1), which theoretically no longer contain any
molecules of the original substance, restored the immune
response as demonstrated by the normal antibody production
of the adult animal in response to antigen stimulus (bovine
thyreoglobulin). Moreover, an improved response of the
pituitary–adrenocortical axis was shown by measuring adreno-
corticotropic hormone. Moreover, in early embryonically
bursectomized chickens, the plasma melatonin response to
immunization by porcine thyroglobulin has found to be
abolished (14,16). Conversely, administration of either minute
amounts (100 pg, 100 fg) or highly dilute (5 · 1027 g) bursin,
with the exception of a highest dose (100 mg), to bursaless
embryos induced recovery of normal antigen-induced
melatonin response. The authors suggest that early in embryo-
nic life, the bursa fabricii and its derived signal (bursin) are
essential for normal development of pineal synthetic activity
and underline the efficacy of very dilute bursin as an informa-
tive signal (17).
Minerals and Nosodes
A series of studies examined the action of high dilutions of sil-
ica on the production of platelet activating factor (PAF) by
peritoneal macrophages in the mouse (18). The compound
was added to drinking water at a dilution of 9c (corresponding
to a theoretical concentration of 1.66 · 1019 M) for 25 days.
The peritoneal macrophages extracted from the mice showed
an ability to produce PAF in response to a stimulus with yeast
extracts that was 30–60% greater than that of control macro-
phages (untreated mice, mice treated with NaCl in a 9c dilution
or with another homeopathic drug, Gelsemium 9c). Lower
dilutions (5c) paradoxically had less effect.
For centuries, homeopathic practitioners have claimed that
serially agitated dilutions of infectious agents (called
‘nosodes’) are effective in the prevention of infectious disease.
Following this idea, an experimental trial of the immunostimu-
lating power of high dilutions of pathogenic substances was
done by a team of American researchers (19,20). They pro-
duced the dynamized dilutions from reticuloendothelial tissue
of mice infected with Francisella tularensis, the microbial
agent of tularemia, obtaining three dilutions containing origi-
nal tissue (3x, 7x and 12x) and three dilutions beyond the
presence of original tissue (30c, 200c and 1000c). These prepa-
rations were administered orally to a group of mice (0.03 ml,
three times per week) for 1 month before and after challenge,
whereas another control group was treated with dilutions of
ethanol. Animals were challenged with a potentially lethal
dose (LD50 or LD75) of F. tularensis, then evaluated for time
of death and total mortality. After 15 experiments the very
high homeopathic dilutions brought about a significant
increase in survival time and a significant reduction in total
mortality compared to controls. Protection rates averaged
22% over controls compared to 100% protection by standard
vaccination. A partial protection was thus obtained from
a nosode of tularemia, in dilutions below those expected to
have protective effects, but not as great as those produced by
standard vaccination.
Homeopathic dilutions of silica are widely used in homeo-
pathy to treat sores, chronic ulcers and abscesses. An experi-
mental animal model based on induced chronic wounds was
used by a group of investigators in Rehovot (Israel) (21),
who reported the therapeutic effects of homeopathic silica
dilutions on the repair of holes pierced in the ears of mice.
The holes were made using dental wire, which was then left
hanging from the ear in order to cause persistent mechanical
irritation. In each experiment, 3 or 4 groups of 10 mice each
were treated by adding homeopathic dilutions of silica
(10–10, 10–60 and 10–400) or saline (10–10) to drinking water
for 4–20 days. The size of the holes was measured every
second day and/or by means of an objective image analysis
system. The results showed that, in 7 out of 11 experiments,
the holes in the ears of the silica-treated animals were signi-
ficantly smaller (P < 0.05–0.001) and healed faster than
those in the saline-treated animals. The therapeutic effect
also progressively increased with increasing silica dilutions.
Interestingly, silica is one of the few homeopathic sub-
stances that have also been investigated by physical instru-
mentation: variations in the nuclear magnetic resonance
characteristics and, in particular, relaxation times T1 and T2
in highly diluted solutions of silica have been measured by a
French research team and published in an official journal
of physics (22). In brief, it was observed that silica/lactose
solutions prepared in centesimal dilutions according to homeo-
pathic methodology led to an increase in T1 and the T1/T2
ratio in comparison with distilled water or diluted and dyna-
mized solutions of NaCl. These changes were also detectable
at silica concentrations in the order of 1017 mol l1. This
was therefore the first case in which a physical characteristic
was described in a homeopathic remedy whose biological
activity was also established experimentally in animals. Unfor-
tunately, these experiments have not yet been replicated by
other groups.
Other Homeopathic Medicines
Atropa belladonna and Echinacea angustifolia have been
tested for their effects on leukocyte migration and macrophage
activity induced by experimental peritonitis in vivo (23). Mice
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were injected (i.p.) with lipopolysaccharide (1.0 mg kg1) and
treated (0.3 ml per 10 g per day, s.c.) with different forms
of these medicines. The association of A. belladonna and
E. angustifolia in a formulation containing various potencies
produced a significant increase of polymorphonuclear cell
migration and a decrease of mononuclear cell percentages.
The proportion of degenerate leukocytes was lower in the
treated groups, compared to a control group. The treated
groups showed increased phagocytosis, mainly in preparations
containing high potencies. The authors suggested that
A. belladonna and E. angustifolia, when prepared ‘in accord
of potencies’, modulate peritoneal inflammatory reaction and
have a cytoprotective action on leukocytes.
Trichinellosis caused by the gastrointestinal nematode
Trichinella spiralis occurs in humans, domestic animals
and wild animals. A recent study (24) investigated whether
potentized homeopathic drugs such as Cina, Santoninum
and Podophyllum can affect the muscle phase of the
parasite in mice. Cina 30 and Santoninum 30 were prepared
from the mother tincture of the flowering tops of Artemisia
nilagirica and its active principle santonin, in each case by
successive dilution (1 : 100) with 90% ethanol and sonication
in 30 steps following the single glass method (30K).
Each drug was diluted 1 : 20 with distilled water and adminis-
tered orally at 0.05 ml per mouse per day. Experimentally
infected mice were also treated with an aqueous Podophyllum
suspension (mother tincture) at 60 mg per kg per day. Each
mouse was inoculated with T. spiralis larvae and treatment
was started on day 7 post-infection and continued for
120 days. After completion of treatment, the mice were
sacrificed and the larvae were extracted from muscles by
HCl–pepsin digestion. The results showed that Podophyllum,
Cina 30 and Santoninum 30 reduced the larval population in
the studied mice by 68.14, 84.10 and 81.20%, respectively,
as compared to the untreated control group. The homeopathic
dilutions were more effective than the mother tincture, an
effect which was not due to the medium ethanol. In fact,
homeopathic dilutions of ethanol (Ethanol 30) achieved
no significant reduction in the larval population compared
to the untreated control group. The authors suggested that
the effect of Podophyllum mother tincture might be due
to the direct toxic effect of the drug on the larvae, while
the homeopathic dilutions of Cina and Santoninum pro-
bably acted through indirect effect, possibly mediated by
immunostimulation.
Canova is a homeopathic complex medicine (composed
of 19x Thuya occidentalis, 18x Bryonia alba, 11x Aconitum
napellus, 19x Arsenicum album and 18x Lachesis muta)
whose effects have been studied in normal and sarcoma
180-bearing mice (25). The mice were examined at daily
intervals and the tumors observed histologically. A delay
in the development, and a reduction in size of the tumors,
and increased infiltration by lymphoid cells, granulation tissue
and fibrosis surrounding the tumor were observed with
active treatment compared to control. All animals from the
treated group survived, 30% of control groups died. In 30%
of treated animals, a total regression of the tumor was con-
firmed using light microscopy, no regression was found in
the control groups. Active treatment increased total numbers
of leukocytes and lymphocytes, suggesting that protection
against experimental sarcoma may result from enhanced
immune response of the host.
The major findings of this line of experiments are
summarized in Table 1.
Immunoregulation and Regulation of the
Inflammatory Processes
The most notable principle of homeopathy means that when
a substance is able to induce a series of symptoms in a healthy
living system, it would be also able under certain circum-
stances to cure these symptoms when applied at low doses
Table 1. Models of homeopathic immunostimulation
Animal Model Treatment Key findings Reference
Mouse Iso-endopathy Low doses of thymic hormones and
interferons
Immunostimulation (7,8)
Mouse Isopathy High dilutions of antigen Specific sensitization (11–13)
Chicken Iso-endopathy High dilutions of peptide hormone Immunostimulation and
neuroendocrine regulation
(7,14,15,17)
Mouse Isopathy High dilutions of silica Stimulation of macrophages (18)
Mouse Isopathy High dilutions of silica Speeds up wound healing (21)
Mouse Isopathy (nosode) Low doses and high dilutions of
infectious agent F. Tularensis
Protection from specific infection (19,20)
Mouse Simile Various dilutions of A. belladonna
and E. angustifolia
Stimulation of phagocytes (23)
Mouse Simile High dilutions of Podophyllum,
Cina 30 and Santoninum 30
Protection from infectious agents (24)
Mouse Simile Complex formulation made by high
dilutions of Thuya, Bryonia,
Aconitum, Arsenicum and Lachesis
Protection from tumors, immunostimulation (25)
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(‘similia similibus curentur’). This concept has a strict rela-
tion with modern immunological evidence of non-linear or
even opposite responses to antigens, cytokines and other
immunoregulatory agents. Therefore, the use of the ‘simile’
in this modality is aimed to decrease the immune and inflam-
matory reactions that occur in many conditions ranging from
local symptoms of immediate allergy to systemic pathologies
associated with chronic autoimmune diseases.
Models of Specific Immunotherapy
Allergen-specific immunotherapy is the only immunomodula-
tory treatment that may alter the natural course of allergic
disease, for example, by preventing the development of
asthma in rhinitic patients (26,27). It consists of injecting
increasing amounts of offending allergens into sensitive
patients with the intention of reducing their level of sensitivity
to allergens. The therapy is believed to exert its effects by
a combination of means: by the induction of blocking anti-
bodies; a switch from a T helper (Th)2 to a more Th1 allergen-
specific immune response; and induction of anergy, probably
via the development of allergen-specific regulatory T cells
(28). The evolution of new developments, including the
sublingual administration of the relevant antigens and new
forms of antigen to regulate the immune system, now offers
improvements in both the safety and the efficacy of specific
immunotherapy (27,29).
In laboratory animals, the secondary immune response to
antigens is depressed (state of tolerance) both in animals
pretreated with very low doses and in animals receiving high
doses of antigen. Pretreatment with intermediate doses,
however, cause a priming, revealed by secondary response
greater than that of non-pretreated animals (30,31). Similarly,
the autoreactivity of T cells is managed by the immune system
in at least two different ways that obviously depended on the
antigen concentration they encounter. If they come into
contact with high concentrations of a self-antigen, they are
deleted (killed) but, when given low doses, they undergo a
special kind of active inhibition (31–33). The mucosal milieu
and the presence of cytokines like IL-4 or IL-10 may enhance
this phenomenon (34–37). Other authors have suggested that
this type of regulation induced by very low substance con-
centrations could serve as a model to explain the way in whi-
ch at least some homeopathic pharmaceuticals mediate
their therapeutic effects (38). Therefore, use of sublingual
immunotherapy is a typical field in which the boundaries of
homeopathy (the so-called isopathic approach) and conven-
tional immunology often overlap.
Adjuvant Cures Adjuvant
A series of studies carried out by our group have considered
specific immunomodulation in rat. Briefly, after the injection
of Freund’s adjuvant (a special non-infective preparation of
Mycobacterium butyricum in paraffin oil used to stimulate
the immune system) in one paw, Lewis rats develop a local
inflammatory reaction. Then, after an interval of about
2 weeks, they develop a picture of arthritis in their other limbs
that is considered to be a model similar to rheumatoid arthritis.
On this type of reaction pharmacologists use to test the
conventional anti-inflammatory drugs. We have demonstrated
(39–41) that this picture of systemic inflammation is greatly
Figure 1. Regulation of adjuvant arthritis by low doses of adjuvant. Rats with adjuvant (killed M. butyricum in paraffin oil)-induced arthritis were injected
intraperitoneally with the causative antigen at concentrations 10 times lower than the inducing one, on the 3rd and 10th day after arthritis induction. The severity
of the disease was assessed on the basis of paw swelling, of general inflammatory involvement (arthritis index) and of biochemical (serum IL-6) parameters
(39,40,42).
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reduced and slowed by the intraperitoneal injection of small
doses of Freund’s adjuvant (0.06 mg in two administrations)
(Fig. 1). This therapeutic effect was both antigen-specific,
because intraperitoneal aspecific inflammation, induced by
casein, did not prevent the disease, and long-lasting. The
results obtained in this model confirm the possibility of
modulating the autoimmune process even when the immunolo-
gical response is already triggered, suggesting new therapeutic
strategies, more suitable than preventive vaccination, in
human autoimmune diseases. In a subsequent study (42), we
investigated the correlation between the therapeutic effect of
low doses of Mycobacterium and endogenous mediators of
inflammation (nitric oxide and cytokines). The treatment
was associated with a significant reduction in IL-6 serum
concentrations, a slight decrease in IFN-g production by peri-
toneal macrophages and an increase in nitrite/nitrate plasma
concentrations, without any apparent differences in peritoneal
macrophage nitric oxide production. Our data show that,
among the variables investigated, IL-6 seems to be the more
representative marker of disease and the effect of treatment,
and that nitric oxide may play a role as a modulator rather
than a direct mediator in this model of inflammation. The
pathological roles of IL-6 have also been clarified in various
disease conditions, such as inflammatory, autoimmune and
malignant diseases. A new therapeutic approach to block
the IL-6 signal using anti-IL-6R antibody for rheumatoid
arthritis, Castleman’s disease and multiple myeloma has been
attempted by various authors (43). Connected with the
mechanisms of this immune tolerance, it has been shown that
the modulation of adjuvant arthritis can be obtained in Lewis
rats by intranasal administration of mycobacterial 10 kDa
heat shock protein (hsp10), indicating that molecular mimicry
by this protein moiety is responsible of immune tolerance and
immune deviation (44).
Tolerance of the ‘‘Simile’’
The specific immune tolerance effect is on a borderline
connecting some of the themes of modern immunopharmaco-
logical research with the most traditional concepts of home-
opathy insofar as it is a further example of the induction of
immunological tolerance by means of low antigen doses, an
immunomodulatory procedure that has been widely revealed
over recent years in a large number of human conditions. We
can here cite only briefly some examples of therapy that can
be considered particular applications of the ‘simile’ at molecu-
lar level (45–50): bacterial endotoxins as immunostimulants,
immunoglobulins to treat immune disorders, orally adminis-
tered myelin in multiple sclerosis, oral collagen in rheumatoid
arthritis, bacterial extracts in recurrent bronchitis and locally
administered allergens in allergies. Specific immunosuppres-
sion and the induction of tolerance by means of microdoses
of antigens (also in the field of allergology) are frontiers of
modern immunology that apply a principle first proposed by
homeopathy in a scientifically controlled manner: the use of
a pathogenic substance for therapeutic purposes by exploiting
very low doses or particular administration protocols (51,52).
Tumor immunotherapy using antigen-pulsed dendritic cells
(53) or autologous tumor-derived heat shock protein prepara-
tions (54) are also worth mentioning in this context.
Table 2 shows some experimentally induced inflammatory
diseases in animals that have been treated by using very low
doses of the ‘simile’ substance, which is the same or similar
substance that causes the disease. This is an application by
modern immunology of the traditional ‘isopathic’ method,
associating two main principles of homeopathy—the low
dose and the similarity between causal and therapeutic agent—
that was introduced by ancient homeopaths like Hering and
Lux (56). Sometimes, also major scientific journals acknowl-
edge (albeit ironically) that the principles of oral tolerance
are connected to homeopathy: ‘The oral-tolerance idea,
discredited and regarded almost as homeopathy by some, was
put into practice to find out whether it works in multiple
sclerosis and rheumatoid arthritis...’ (57). Needless to say, all
these advancements of the ancient isopathic idea in modern
immunology do not support the use of homeopathic medicines
as immunomodulators in humans, a possibility that should be
explored by appropriate clinical studies.
Models of Acute Inflammation
In the previous lecture dealing with the effect of homeopathic
dilutions at the cell level (6) we noted that according to several
authors high dilutions of Apis mellifica (a medicine which is
currently used in homeopathy to treat skin manifestations
with edema, erythema and itch) inhibit basophil activation,
this line of research illustrating a laboratory application of
the principle of similarity: a substance known to stimulate
inflammation at conventional doses can, at different doses,
inhibit the cells responsible for many of the phenomena of
Table 2. Treatment of organ-specific autoimmune diseases in animals
using the ‘simile’ substance at very low doses [adapted from
ref. (40,49,55)]
Model disease ‘Pathogenic’
compounds
‘Therapeutic’
compound
Experimental allergic
encephalomyelitis (Lewis
rat, guinea pig)
Myelin Myelin basic protein
Oral: 3–10 mg (no
effect with 50 mg)
Aerosol: 0.005–5 mg
Collagen-induced arthritis
(Lewis rat)
Collagen Collagen type II
and type I
Oral: 0.003 mg
(no effects of 0.3 mg)
Spontaneous autoimmune
diabetes (mouse)
Pancreas islet
antigens?
Insulin
Oral: 1 mg (no
effect with 5 mg)
Experimental autoimmune
myasthenia gravis
(Lewis rat)
Acetylcholine
receptor
Acetylcholine receptor
Oral: 20 mg
Arthritis induced by
mycobacterium extract
(Lewis rat)
Mycobacterium
extract (heat-shock
protein?)
Mycobacterium extract
Intraperitoneal:
0.06 mg
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the inflammatory process. Early studies of French researchers
reported that high dilutions (7c to 9c) of bee (A. mellifica)
and its venom (Apium virus), have a protective and curative
effect on 50% of X-ray induced erythema in albino guinea
pig (58–61). This seems to confirm the principle of reactional
similarity underlying homeopathy. It is well known that high
doses of bee venom (such as that delivered by a sting) cause
edema and erythema, but homeopathic dilutions can cure the
edema and erythema caused by another agent. This line of
research is quite interesting, but the results await independent
confirmation because the methodological quality of the first
publications was low (5).
Following a similar experimental idea, our group at the
University of Verona (in a line directed by Dr Conforti)
studied the effects of homeopathic preparations of A. mellifica
and Histamin on rat paw edema (measured as the swelling due
to the accumulation of exudate) induced by the injection of
inflammatory doses of histamine. Using this model, it was
observed that high dilutions of up to 30x had a small but
significant inhibitory effect on the development of edema
(62). This was a pilot investigation that unfortunately we had
no opportunity to pursue further due to lack of funding.
Complex Formulations
Carrageenin edema, a classical experimental model commonly
used to test the activity of anti-inflammatory drugs, was used
by our group (63) to evaluate the therapeutic activity of a low-
potency mineral complex called Ultima ratio (MC), consti-
tuted of different salts, at various potencies (2x to 7x): potas-
sium bromide, potassium sulfate, calcium chloride, strontium
chloride, barium chloride, manganese sulfate, iron sulfate
and others, prepared according to the German pharmacopoeia.
The MC was administered in the right plantar surface of albino
rats 60 min before, simultaneously and 30 min after the injec-
tion of carrageenin, an irritant which causes a local and tran-
sient increase in fluid volume. The administration of the MC
60 min before the injection of carrageenin primed an enhanced
inflammatory response to the irritant. The administration of
MC at the same time as carrageenin did not modify the kinetics
or the extent of the edema, whereas the administration of the
MC 30 min after the induction of edema significantly reduced
the early phase of the inflammatory reaction. This suggests
that the therapeutic action of this MC is not due to conven-
tional anti-inflammatory effects but to the activation of
endogenous regulatory mechanisms, something that may be
regarded as a simple application of the ‘similia rule’.
Our group has also carried out a series of studies on the
activity of a homeopathic formulation (Traumeel-S, TRS) con-
taining low potencies (4x to 12x) of Arnica montana and other
plant extracts and minerals (Calendula officinalis, Hamamelis
virginiana, Achillea millefolium, A. belladonna, Aconitum
napellum, Hepar sulfuris, Symphytum, Mercurius solubilis,
Bellis perennis, Chamomilla, E. angustifolia, Echinacea pur-
purea, Hypericum) on an animal model of inflammation
(64,65). The main indications of TRS refer to different types
of lesions and inflammatory processes involving muscles and
joints, sprains and bruises. We tested the in vivo effects of
TRS on acute and chronic experimental inflammatory condi-
tions caused by the intrapaw injection of carrageenin (car-
rageenin edema) or Freund’s complete adjuvant (adjuvant
arthritis). The results suggested that the local administration
of TRS reduced the development of edema in a way that is
similar to the effect of aspirin at a dose of 30 mg kg1 in the
same experimental model. In the adjuvant arthritis model, the
i.p. administration of TRS every 2 days led to a significant
reduction in acute local inflammation, without affecting the
chronic arthritic process.
Figure 2. Effect of Traumeel-S on the rat paw edema caused by autologous blood injection. Adapted from data of ref. (66). *P < 0.05, **P < 0.01.
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Furthermore, we carried out a series of studies aimed at
improving the knowledge of the therapeutic action of TRS
using a new model represented by the intrapaw injection of
a small amount of homologous blood mimicking traumatic
blood extravasation, a condition that is usually treated with
TRS (66). We also measured the serum level of IL-6,
a cytokine known to be involved in inflammatory conditions.
The results (Fig. 2) showed a slight but significant decrease
in paw edema associated with the process of healing, which
was more rapid in the rats treated with TRS (P < 0.05 after
3 and P < 0.01 after 5 h). Similar effects were also induced
by separate injections of most, but not all of the ingredients
of TRS. The efficacy of the complete TRS mixture was greater
than that of the combination of a selection of active compo-
nents. The therapeutic effect was associated with a significant
decrease in systemic IL-6 production. In conclusion, TRS
seems to act by speeding up the healing process instead
of blocking the development of edema from the beginning.
Moreover, its effect cannot be considered as the ‘sum’ of its
active components but is probably due to synergistic inter-
actions. The main results of our experiments in rat models of
inflammation are summarized in Table 3.
Experimental Discrepancies in Homeopathic Doses
We have more recently repeated the tests of anti-inflammatory
power using individual homeopathic dilutions in a series of
experiments performed in collaboration with the Istituto
Superiore di Sanita` of Italian Health Ministry (A. Conforti,
P. Bellavite, S. Bertani, F. Chiarotti, F. Menniti-Ippolito,
R. Raschetti, 2006, submitted for publication). Aim of the
study was to evaluate, through two randomized controlled ani-
mal experiments, the activity of different homeopathic reme-
dies (A. montana, A. mellifica, A. belladonna, H. virginiana,
Lachesis and Phosphorus), usually prescribed by homeopaths
to treat inflammatory or hemorrhagic manifestations. Two
control drugs were used: saline (placebo) and indomethacin
(active reference treatment). In experiment A more conditions
were tested (six homeopathic remedies, two administration
routes—oral and by subplantar injection—and two edema
models—carrageenin- and autologous blood-induced
edema). Some small, but statistically significant, effects of
homeopathic remedies were observed. The most relevant
results concerned Apis (4x), Lachesis (6x) and Phosphorus
(6x) in the oral treatment of carrageenin-induced edema (vol-
ume reduction ranging from 11 to 28%). When retested in
experiment B, following a blinding procedure as for treatments
allocation and measurement of the outcome, the three homeo-
pathic remedies (both at low and at high dilutions) did not
show any anti-inflammatory effect. The activity of
indomethacin was reproduced in both experiments. In conclu-
sion, the different results observed in the two experiments
make it possible to draw some suggestions useful for designing
possible further experiments, among these the discrepancies
between single-blind and double-blind methods in animal
pharmacological research are noteworthy and should be better
investigated, also in non-homeopathic research. In this type of
research, several technical factors linked to sensitivity of the
tested system, to the type medicines used (e.g. single remedies
versus complex formulations, oral administration versus local
injection) and even to the type of solvent used for the solutions
(water, saline, water/alcohol mixtures) that can affect the
drug stability and efficiency (24,67) may explain the observed
discrepancies and the lack of reproducibility that we and others
have often observed.
The effect of A. montana on the classical rat model of
paw inflammation was evaluated by others, using acute and
chronic models (68). In the acute, carrageenin-induced rat
paw edema, the group treated with Arnica 6c showed 30%
inhibition compared to control group (P < 0.05). In nystatin-
induced edema (chronic model) the group treated 3 days
previously with Arnica 6c had reduced inflammation 6 h after
the inflammatory agent was applied (P < 0.05). When
homeopathic treatment was given 6 h after nystatin injection,
there was no significant inhibitory effect. In a model based
on histamine-induced increase of vascular permeability,
pretreatment with Arnica 6c blocked the action of histamine.
Homeopathic Dilution of Allopathic Drugs
Special interest for the interpretation of the similia principle
may have the study of the effects of homeopathic dilutions
of conventional (allopathic) anti-inflammatory medicines. A
Brazilian group (69) has evaluated the interaction of dexam-
ethasone 7c and 15c (equivalent to 1017 and 1033 M) with
dexamethasone in pharmacological concentrations, using as
experimental models based on the acute inflammation induced
by carrageenin into the footpad for edema evaluation or in
peritoneal cavity for polymorphonuclear cell migration.
Animals were treated with the following preparations: (i)
phosphate-buffer saline (PBS) solution; (ii) dexamethasone
(0.5 mg kg1 for inflammation model or 4 mg kg1 for tumor
model) mixed with dexamethasone 7c or 15c; and (iii) dexam-
ethasone (same doses) mixed in PBS. Homeopathic dexam-
ethasone partially blocked the anti-inflammatory effect of
pharmacological dexamethasone with regard to paw edema
(P < 0.0008) and polymorphonuclear cell migration into the
peritoneal cavity (P ¼ 0.0001). The results demonstrate that
Table 3. Effects of the homeopathic complex Traumeel-S or of its single
components on experimental models of acute and chronic inflammation
Inflammation
inducer
Type of
inflammatory
reaction
Route of
administration
Key effects Reference
Carrageenin Acute (1–7 h) Local injection Slight inhibition
of edema
(64)
Freund’s
adjuvant
Acute
(2–4 days)
Intraperitoneally Inhibition of
local reaction
(64)
Chronic
(14–28 days)
Intraperitoneally No effect on
systemic reaction
(64)
Autologous
blood
Acute (1–5 h) Local injection Speeds up
edema resolution
(66)
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a potentized substance may have opposite effects on its own
pharmacological effects and suggest that high dilution effects
act also on specific parameters of host response.
Another model showing an experimental proof of the
concept of homeopathic simile was recently reported (70).
Causticum is a homeopathic medicine that when administered
in ponderal doses into the hind paw of rats produced an inflam-
matory reaction with edema formation within the first hour,
showing that Causticum acts as an edematogenic agent.
Carrageenin induced rat paw edema was significantly inhibited
in rats treated with Causticum 6c, 12c, 30c and 200c dilutions
compared to untreated rats.
The anti-inflammatory and antithrombotic effect of high
dose acetylsalicylic acid (ASA) is well known, and recently,
animal studies hinted the thrombotic effect of ultralow dose
of ASA. A laser-induced rat mesenteric vessel thrombosis
model was used to evaluate the effect of ASA at ultralow doses
in Wistar rats. Compared with placebo, the administration of
ASA at ultralow doses (15c diluted and succussed solutions
containing a theoretical dose of 1030 mg kg1) induced an
increase in number of emboli and an increase in the duration
of embolization (71–73). Since it is well known that aspirin
causes an increase in bleeding time at pharmacological doses
(50–500 mg), the findings of these studies may possibly be
interpreted as a demonstration of the law of similars. Never-
theless, the mechanism whereby this happens is still unclear
because, while we know that aspirin at normal doses exerts
its action by inhibiting the function of platelets, in the early
work by the same group it is reported that homeopathic dilu-
tions of aspirin have no effect on platelet aggregation (74). In
further studies (75,76) homeopathic preparations of ASA
(15c), injected 2 or 3 h after the administration of aspirin at
100 mg kg1, inhibited the antithrombotic effect of high-dose
ASA. These paradoxical and opposing effects of different
doses of aspirin could be of importance for the long-term use
of this common drug and possibly for prevention or the
treatment of hemorrhagic syndromes.
Application of experimental stress (such as unavoidable
footshock) induce gastric erosions and immunological alter-
ations in mice. Low dilutions of A. belladonna L., Gelsemium
sempervirens L. and Poumon histamine showed a significant
immunoprotective and gastroprotective effect in mice exposed
to this experimental stress (77). Immunological studies were
investigated to count white blood cells subpopulations
(lymphocytes, neutrophils, monocytes and basophils) by
coulter counter. The authors suggested that the immunological
protective effects observed were probably induced via a neuro-
tropic effect of the tested medicines.
The main results of this line of experiments are summarized
in Table 4.
Other High Dilution Effects in Animal Models
A team of researchers have reported that homeopathic zinc
preparations in decimal dilutions (from 4x to 12x, correspond-
ing to amounts of zinc ranging from 0.025 mg to 0.25 pg)
administered to rats for seven consecutive days significantly
increases the release of histamine by peritoneal mast cells (78).
It is known that beta-2 adrenergic agonists (isoproterenol,
salbutamol, tulobuterol) relax the tracheobronchial musculat-
ure. It has also been reported (79) that, even at high dilutions
(1020 to 1036 M in dynamized decimal dilutions), they are
also capable of relaxing basal tone in a model of isolated
guinea pig trachea. The fact that visceral smooth muscle may
be sensitive to high dilutions of such hormones is interesting
because of the close relationships between the immune and
neuroendocrine systems, and therefore the possibility that
homeopathic medicines may act at the peripheral or central
level (which is still unknown) of the dysregulation involved
Table 4. Immunoregulation and regulation of inflammatory processes in animal models
Animal Model Treatment Key findings Reference
Rat Isopathy (nosode) Low doses of Freund’s adjuvant Decrease of reactive arthritis
caused by the same agent
(39–42)
Guinea pig Simile High dilutions of A. mellifica and
Apium virus
Curative effect on X-ray induced
skin erythema
(58–61)
Rat Isopathy or iso-endopathy Low doses and high dilutions of
A. mellifica and Histamin
Decrease of histamine-induced
paw edema
(62)
Rat Isopathy or Simile Low doses of homeopathic
mineral complex
Decrease of carrageenin-induced
edema
(63)
Rat Simile Low doses of the homeopathic
complex Traumeel-S
Decrease of edema (see Table 3) (64–66)
Rat Simile High dilutions of A. montana Decrease of edema induced by
various agents
(68)
Rat Simile High dilution of Causticum Decrease of carrageenin-induced
edema
(70)
Rat Iso-endopathy High dilutions of dexamethasone Reduces the anti-inflammatory
effect of dexamethasone
(69)
Rat Isopathy High dilutions of ASA Prothrombotic effect (71–73,75,76)
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in diseases of the inflammatory and immune systems, such as
bronchial asthma and gastroenteritis.
Benveniste’s Effects and Further Studies
One important phenomenon of acute inflammation is
regulation of the blood flux, which can be assessed in isolated
organs. Benveniste and co-workers (80,81) have reported the
results obtained using an experimental model of isolated and
perfused guinea pig heart (Langendoff’s system). Coronary
flow increased with the infusion of very high dilutions of
histamine (>30x) as normally happens with the usual low
dilutions. The blind infusion of buffer alone or a high dilution
of the methyl-histamine analog had no effect on coronary
flow. The vasodilating activity of highly diluted histamine
was abolished by treatment at 70C for 30 min or exposure to
a 50 Hz magnetic field for 15 min (82). The authors concluded
that the water, deprived of solute by means of serial dilutions,
retains a specific activity that can be suppressed by physical
treatments that do not have any effect on the solute itself.
The model of isolated and perfused guinea pig heart seems to
be effective in providing reliable results. In two subsequent
publications (83,84), the same group reported that the system
is also sensitive to immunization-dependent activation. By
immunizing guinea pigs with ovalbumin and removing the
heart after between 9 and 20 days, it was possible to obtain
an increase in coronary flow at extremely high ovalbumin
dilutions (1031 to 1041 M). The authors have opened a web-
site in which they claim to have pursued their research lines
with significant results (http://www.digibio.com).
The homeopathic medicine A. belladonna was tested on the
in vitro contraction of isolated duodenum (85). It is noteworthy
that low dilutions of Belladonna (1c and 5c) showed inhibitory
effects, as expected from the spasmolytic effect of atropin,
while highly diluted and dynamized solutions (30c and 45c)
showed stimulatory effects. Non-dynamized solutions were
inactive.
Veterinary Homeopathy and Cure of Infections
Veterinarians are showing more interest in alternative methods
of farming and of cure, but information about the extension
of homeopathy to veterinary medicine is limited, as good records
of the use of these treatments do not exist. In the treatment
of farm animals, alternative therapies have been in focus mainly
in relation to organic farming, because of the emphasis on
natural methods and medicines in the organic standards and the
general intention to reduce use of chemical substances (86–90).
Preliminary Evidence
The prevalence of resistant bacteria is rising, and organisms
resistant to almost all antibiotics have been identified. The
main causes are indiscriminate prescribing and the use of
antibiotics in animal feeds and other agricultural applications.
Policies to restrict use of antibiotics have had limited success.
Homeopathy may have a role to play in combating the infec-
tious diseases (91) and development of antibiotic resistance
(92). In the pig, the value of using homeopathy (a complex
of Caulophyllum 30c, Sepia 6x and Cocculus 6x) on the
delivery process and on the viability of piglets has also been
suggested (93).
As reported in a preliminary communication, Baptisia
tinctoria 30c was tested with positive results to cure salmonel-
losis in broiler chickens (94). An experimental study sought to
determine the efficacy of isopathic and pluralist homeopathic
treatment of colibacillosis in broiler chickens (95). Three
groups of broilers, infected intratracheally at 8 days of age
with Escherichia coli (O78:K80), were treated with different
combinations of homeopathic remedies. Control groups and
an infected, doxycyline-treated group were included. Efficacy
of treatment was evaluated based on the parameters mortality,
body weight gain and colibacillosis lesions. In both experi-
ments doxycyline prevented mortality and reduced E. coli
lesions and stunting. None of the homeopathically treated
groups differed significantly with respect to any of the parame-
ters from the non-medicated, infected control group. It is
concluded that the results of this study do not justify use of
these homeopathic remedies for treatment of colibacillosis in
broilers.
Mastitis is the major problem of dairy animals despite a
number of preventive and therapeutic approaches. Treatment
is costly and out of reach of farmers of developing countries.
‘Encouraging’ results in cows with acute mastitis were
reported, in uncontrolled studies, with low-potency
homeopathic medicines like Aconitum 4x, Phytolacca 1x and
Bryonia 4x (96). Similar results were reported also by others
(97). More recently, two observational studies investigated
the treatment economics of homeopathic drugs and conven-
tional drugs for the management of bovine mastitis (98,99).
In the second one (99), a reference group (non-randomized)
that was treated with antibiotics was also included in the study.
In the homeopathy group, 96 mastitic quarters (non-fibrosed
67 and fibrosed 29) were treated with the homeopathic com-
bination medicine Healwell VT-6 (consisting of Phytolacca
200c, Calcarea fluorica 200c, Silicea 30c, Belladonna 30c,
Bryonia 30c, Arnica 30c, Conium 30c and Ipecacuanha 30c).
The overall effectiveness of homeopathic combination
medicine in the treatment of acute non-fibrosed mastitis was
86.6% with a mean recovery period of 7.7 days (range 3–28),
and total cost of therapy as d0.39, US$ 0.47. The correspond-
ing cure rate for the antibiotic group was 59.2% with a mean
recovery period of 4.5 days (range 2–15) and an average treat-
ment cost of d2.69, US$ 3.28. In synthesis, the homeopathic
complex medicine may be effective and economical in the
management of bovine mastitis, but definitive conclusions
are premature due to the design of the studies that did not
include radomization and blinding.
Few Randomized Trials
A veterinary randomized clinical trial was carried out in order
to evaluate the efficacy of homeopathy in treatment of clinical
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mastitis in dairy cows (100). A three-armed, stratified, semi-
crossover design comparing classical (individualized) home-
opathy, placebo and a standardized antibiotic treatment was
used. Significant reductions in mastitis signs were observed
in all treatment groups. Two-thirds of the cases both in the
homeopathy and placebo groups responded clinically within
7 days. However, homeopathic treatment was not statistically
different from either placebo or antibiotic treatment. The latter
treatment was significantly better than placebo. Evidence of
efficacy of homeopathic treatment beyond placebo was not
found in this study, but authors suggested that the design can
be useful in subsequent larger trials on individualized homeo-
pathic treatment. Furthermore, the use of a homeopathic
nosode in the treatment of bovine mastitis was unsuccessful
in a randomized trial (101).
Another study conducted in pigs showed that various
combinations of Lachesis, Pulsatilla and Sabina, or Lachesis,
Echinacea and Pyrogenium, associated with Caulophyllum
(all in low dilutions, from 1x to 6x) have prophylactic and
therapeutic effects on infections (metritis and mastitis) of sows
and on diarrhea of piglets (102). A double-blind, placebo-con-
trolled clinical trial of a homeopathic treatment of neonatal
calf diarrhea was performed (103). Calves with spontaneously
derived diarrhea were treated with either the homeopathic
remedy Podophyllum 30x or a placebo. No clinically or
statistically significant difference between the two groups was
demonstrated in the duration of diarrhea, inappetence and fever.
Knowledge of non-invasive treatments with few or no side
effects that have the potential to heal animals should be
welcomed, and homeopathy, as well as other complementary
therapies, fits this description (104). Homeopathy may offer
great advantages in animal farming, particularly for its poten-
tial immunostimulating effects, which in turn would reduce
the need of chemical treatments, but documentation of these
effects is largely insufficient.
Discussion
As in conventional research, animal models are also used in the
field of homeopathy both for testing the principle of dilution/
dynamization and for studying the possible mechanism of
action of homeopathic remedies in a thorough and repeatable
manner, as well as for discovering remedies to be used in the
veterinary context. The aim of this type of experimental
work is to provide a rational approach to the investigation of
the various aspect of the ‘similia similibus curentur’ principle
and of the use of high dilutions, in order to construct a plausible
framework of ideas capable of facilitating further basic and
clinical research into these historical yet also modern medical
principles. Acceptance of the homeopathic claims requires
supporting evidence of plausible mechanisms and high quality
studies exploring its effectiveness in experimental settings.
The Mosaic of Homeopathic Research
The problems raised by homeopathy are very wide and com-
plex, so it is not the matter of a single experiment that can
clarify everything of homeopathic theories. ‘There is not a sin-
gle point whose clarification will explain everything, there is
no a single ‘‘Nobel-prize’’-experiment that could ‘‘prove’’
homeopathy.‘ Instead, the picture of homeopathy is at present
going to be clarified like a puzzle or like a mosaic whose
pieces are progressively going in the right place, where all
the little pieces are important for the realization of the whole
image.
The studies referred to here do not cover all the homeopathic
literature of animal research but only those dealing with
immunity and inflammation. As in all fields of research it
is important to establish the goals of experimental studies.
Animal studies in homeopathy refer to three main goals,
namely (i) preclinical research to test in animals the medicines
before their utilization in human beings; (ii) finding new, non-
toxic therapies for animals in veterinary research; and (iii)
exploring in controlled and reproducible settings specific
aspects and mechanisms of action of homeopathic approach.
All these goals appear very important and urgent, but none of
them can answer the question of whether homeopathy is an
effective cure for humans.
Starting from the first point, the preclinical research in
homeopathy has virtually never pursued and the situation is
inverted with respect to conventional pharmacological
research. In fact, homeopathy is founded on human ‘provings’
and medicines have been employed in humans for two cen-
turies without verification of their effects in animal models.
Only in the recent decades, some groups have begun testing
in animal models some already commercially available
homeopathic medicines, especially low-dose complex formu-
lations. The main studies in immunological and immuno-
pharmacological fields have been here reported and gave, in
general, positive results. Even if these medicines are already
in the human use, pursuing this line of research in animals
could be useful to better identify new fields of pathologies
where those medicines could be potentially employed and
to improve formulations as regards their constituents and/or
their grade of dilution.
As the veterinary research is concerned, the authors of this
review have searched literature regarding immunostimulating
effects of homeopathy and/or protection from infectious dis-
eases. In addition to Internet databases, books and conference
proceedings, we have also directly asked homeopathic veterin-
ary associations and private foundations to provide available
literature. Unfortunately, we were able to find only a few arti-
cles on these topics. The Carstens Foundation kindly provided
a list of veterinary studies but most of them were unpublished
university dissertations. So, to the best of our knowledge, the
question of the potential utilization of homeopathy in the
infectious diseases of domestic animals or in natural farming
is still largely unexplored, or unpublished.
The study of the mechanisms of therapeutic action would be
the main goal of basic research in homeopathy. Here, two
major themes are under investigation, namely, (i) the ‘high
dilution’ effects, i.e. the question whether and how substances
diluted (and dynamized) in away that few or no molecules of
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active principle may have pharmacological effects; and (ii) the
mode of action of the ‘simile’ effect, i.e. how a substance
known to have pathogenetic effects in healthy organisms
(cells, animals and humans) may turn to become a therapeutic
agent in diseased organisms. These two themes may be in turn
split in a number of minor questions regarding the methods of
dilution, the most useful model to show the effect, the type of
solvent used (distilled water, saline solutions, water/ethanol
mixtures) and other technical details that may often affect the
final outcomes.
An important point is the distinction between very low
dose and high-dilution effects. Both fields fully belong to
homeopathy, provided that the medicine is prescribed accord-
ing to the similia principle and according to a holistic clinical
approach. From a scientific standpoint, the mechanism(s)
underlying the ‘similia law’ and the effect of microdoses of
drugs can be investigated and understood independently of
the so-called ‘high dilution’ or ‘high potency’ effect. The
similia principle is the foundation of the homeopathy and the
conditio-sine-qua-non of its definition. Hahnemann started its
system by utilizing low doses of drugs that were available at
his time. The principle of ‘dynamization’ or ‘potentization’
was established in subsequent years, after a number of experi-
mental trials. Moreover, even now the major portion of the
market of homeopathic medicines in Europe is represented
by low-dilution medicines containing very low doses of active
principles in the molecular range. It is worth noting that
homeopathic dilutions in the range of 10x to 20x (5c to 10c)
may theoretically contain molecules in a range of extremely
low concentrations (1010 to 1020 mol l1) that have been
shown to be biologically active in ‘conventional’ biochemistry
and immunology (2).
Aims and Limits of Animal Models
As noted in the case of in vitro studies (6), also the animal
research in laboratory is by its nature a reductionistic one:
while it should allow better definition of single problems, it
loses the ability of evaluating a therapeutic approach in all its
integrity. In classical homeopathy, as well as in most other
alternative approaches, a holistic view of disease is empha-
sized, and individual judgement and treatment is important.
This implies that when choosing the homeopathic remedy,
attention is focused on the totality of the organism as a whole,
including personality and behavior, and not merely on symp-
toms related to the affected organ system. As a consequence,
any reductionistic experimental approach must be taken for
the scientific advancements that may allow, but not as a ‘proof’
or a ‘prove to be wrong’ of homeopathy itself. Therefore, care
should be always applied in the interpretation of results from
animal studies with respect to possible mechanisms of action
of homeopathy. Finding a direct effect of a homeopathic dilu-
tion in a cell model or in a animal model of inflammation
(e.g. foot edema, skin rash, etc.) may indicate a ‘local’ effect
of the medicine, for example, at the receptor level. However,
inflammation has always a complex neurohumoral regulation
and indirect or systemic pathways of regulation cannot be
excluded.
Most of the studies reported here, including ours, have
explored what is conventionally denoted as pharmacological
‘activity‘ on one symptom (e.g. foot swelling). While conven-
tional anti-inflammatory drugs are designed to suppress the
symptom pointing to the underlying enzymatic mechanisms
(e.g. prostaglandin production), homeopathic treatment is sup-
posed to regulate the pathological excess of inflammation
because the phenomenon by itself is seen as an expression
of natural healing dynamics (the so-called Hahnemann’s
‘life force’). According to classical homeopathic theory, an
‘anti-edema’ effect could not reflect the full potential of the
homeopathic treatments of inflammatory diseases.
For example, high dilutions of histamine may act either
on basophil regulation of local blood supply or vascular per-
meability, as shown in above mentioned reports (105), or as
a neurotropic drug and central neurotransmitter, as recently
reported by others (77,106). The latter report showed that
ultradiluted histamine (30c) increases arousal of Wistar rats
via H1 receptors and in the EEG lowers the mean delta band
spectral density as compared to the control group. Significant
differences between histamine 30c and baseline during the first
2 h imply an immediate effect.
High Dilution Effects
As far as the proof of effects of solutions diluted beyond
the Avogadro constant are concerned, the studies on animal
models appear to parallel those on isolated cells (6): as a matter
of facts, there are several reports claiming to have demon-
strated significant modifications of some physiological
parameter or vitality of animals treated with high potencies
of homeopathic medicines or with high dilutions of other
pharmacologically active compounds. On the other hand, the
state of the art illustrates the preliminary nature of most reports
and the lack of independent replications, so that definite
conclusions on the efficacy of highly diluted homeopathic
medicines in specific conditions would be premature.
Finding a rationale and systematic approach to the high dilu-
tion and dynamization phenomenon would also require more
knowledge of the physicochemical state of the solution
employed. There is a number of theoretical and experimental
advances suggesting the existence of peculiar physicochemical
states in water, compatible with the hypothesis that structure
(and information) can be stored in liquid water (22,67,107–
116), while others studies carried out with magnetic resonance
spectroscopy could not confirm these models (117,118).
Therefore, proofs of the presence of stable structures in water
are not so consistent and reproducible as it should be for a gen-
eral acceptation by the scientific community. Skeptics are not
convinced by the available evidence. On the other hand, peo-
ple with more ‘open-minded’ position are reinforced in their
belief that ‘anomalous states’ of water and ‘condensed matter
physics’ are giving to high-dilution/high potency homeopathy
an increased credibility (119).
182 Homeopathy and immunology. Animal studies
Our belief is that many ‘high-dilution’ experiments point
out elusive physicochemical and biological phenomena that
really occur in nature, associated with the structural and
dynamical properties of water and water/alcohol solution, but
they are difficult to be reproduced in laboratory settings (6)
because the subtle information possibly associated with ultra-
high dilutions can theoretically affect only highly sensitive,
far-from equilibrium and unstable systems. As a consequence,
they are markedly affected by minimal technical differences
and conditions, as postulated by the dynamic systems
theory on chaotic phenomena (3,120). Homeopathy used
with ultradiluted drugs may be regarded as a new paradigm
of communicating biological information in complex systems,
a paradigm that has been also designed as ‘the body signifier’
(121,122). The potential strength of the method consists in the
fact that, by using an analogical reasoning (similitude) and
information-specific long-range signals of biophysical nature,
it attempts to achieve a systemic level of regulation of
the body.
The Extensive Phenomenon of Biological ‘Similitude’
Several lines of evidence indicate that the above-presented
models of ‘simile’ effects in biological systems are consistent
with a large series of experimental data emerging from various
fields of modern biomedical research. Both in homeopathic lit-
erature and in ‘mainstream’ immunology, there are a number
of examples, both at cellular and at systemic level where the
effect of a certain compound can be either positive (e.g. stimu-
lating or priming) or negative (e.g. inhibiting or blocking)
depending on the doses employed and on the conditions of
the experiments. However, this is only a general indication,
because the clarification of the mechanism(s) underlying
most of the paradoxical effects reported requires further
investigation.
Although many results obtained in animal models are of pro-
visional nature and wait for confirmation, the overall body of
literature suggests that the scientific re-evaluation of the prin-
ciple of similarity is worthy of increasing attention
(1,2,123,124). The first reason is that this concept may repre-
sent a broad overall frame of reference for theoretical models
explaining both a body of empirical observations emerging
from old medical literature and the increasing experimental
evidence of paradoxical results or of apparently opposite
results described by different investigators in fields ranging
from molecular biology to immunology and neurobiology.
If this general frame of reference gains credibility and is
increasingly documented experimentally, some apparent con-
trasts between empirical medical approaches and mainstream
medicine approaches could be reconciled in a rational way.
The second reason why a reappraisal of the principle of simi-
larity appears to be worthy of attention is that it can be used as
a ‘heuristic principle’, i.e. a driving force on the basis of which
new experimental ideas are generated in intellectually curious
medical investigators. Every investigator dealing with a spe-
cific field could design new experiments based on the principle
of similarity. A knowledge of the principle of similarity/
inverse effects phenomena should encourage a positive and
fruitful reappraisal of certain experimental results that may
appear at variance with or even opposed to the starting
hypothesis. Finding unexpected, controversial and paradoxical
results is a common experience in science, but often these
results are ignored and discarded because they do not fit
the main theories (125). The occurrence of inverse effects
according to the general principle of similarity could help
and stimulate scientists to subject these data to a positive
re-think: they will appear as an expression of the
self-recovery phenomena which are typical of complex
biological systems. A very recent paper demonstrated that
the isopathic approach may have further promising applica-
tions also in farming: chickens receiving a treatment made of
30· potency of Salmonella enterica were protected from
salmanellosis as compared to untreated controls (126).
Finally, the principle of similarity could be re-evaluated as
a way of designing therapeutic strategies, according to two
main lines, i.e. either by administering the ‘simile’ as a sub-
stance belonging to a known pathogenetic mechanism of the
disease or administering the ‘simile’ as a compound that
causes similar symptoms. The first line corresponds to the
approach which historically has been called ‘isopathy’ or
‘therapy by nosodes’ and whose current updating consists in
the utilization of a series of agents that are pathogenic when
used at high doses in healthy people and therapeutic when
used at low doses in sick people: cytokines, bacterial products,
specific antigens, nitric oxide, cancer cells modified by genetic
engineering, etc. The second line is followed by classical,
individualized, homeopathy. The effectiveness of these
approaches in human medicine is under increasing debate
and their applications in the immunopharmacological field
will be the object of a further publication of this series.
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